Relationship Between Human Leukocyte Antigen DRB1 and Psoriasis in Iraqi Patients

Overview

Journal Saudi Med J

Specialty General Medicine

Date 2018 Sep 26

PMID 30251731

Citations 2

Authors

Haider H Zalzala

Galawish A Abdullah

Mohammed Y Abbas

Hyam R Mohammedsalih

Batool M Mahdi

Affiliations

Soon will be listed here.

Abstract

Objectives: To investigate the role of Human leukocyte antigen (HLA) Class II DRB1 in susceptibility to psoriasis in Iraqi patients.

Methods: A cross-sectional comparative study including 40 patients with psoriasis attending the Department of Dermatology, Al-Kindy teaching hospital in Baghdad, Iraq, between September 2013-2015. Patient selection was carried out by the dermatologists. Ninety healthy individuals were included in the study. Human leukocyte antigen genotyping was carried out by the sequence specific oligonucleotide (SSO) method using Auto LiPA 48 (Innogenetics, Belgium) in the HLA typing research unit of the Al-Kindy College of Medicine, Baghdad, Iraq.

Results: There is an increased frequency of HLA-DRB1*0102, *0306 in psoriatic patients with psoriasis p-values=0.001, confidence interval(CI)=2.492-37.487 and odds ratio(OR)=9.666. Human leukocyte antigen-DRB1*1101 is significantly associated with plaque-type psoriasis with p=0.0434, CI=1.04-1.69, and OR=4.2. Human leukocyte antigen-DRB1*0102 is significantly associated with other types of psoriasis with p=0.018, CI=0.0223-0.701, and OR=0.125.

Conclusion: Human leukocyte antigen-DRB1*0102 and *0306 are significantly associated with psoriasis. Human leukocyte antigen-DRB1*1101 is significantly associated with plaque-type psoriasis. Human leukocyte antigen-DRB1*0102 is significantly associated with other types of psoriasis rather than plaque-type psoriasis.

Citing Articles

Rituximab-induced psoriasis in a patient with pemphigus vulgaris: A case report and literature review.

Ghadirzade Arani L, Moslemi Haghighi S, Nasiri S, Dadkhahfar S Clin Case Rep. 2024; 12(3):e8541.

PMID: 38464573 PMC: 10923702. DOI: 10.1002/ccr3.8541.

SampPick: Selection of a Cohort of Subjects Matching a Population HLA Distribution.

McGill J, Yogurtcu O, Verthelyi D, Yang H, Sauna Z Front Immunol. 2020; 10:2894.

PMID: 31921155 PMC: 6933600. DOI: 10.3389/fimmu.2019.02894.

References

Krueger J . An autoimmune "attack" on melanocytes triggers psoriasis and cellular hyperplasia. J Exp Med. 2015; 212(13):2186. PMC: 4689173. DOI: 10.1084/jem.21213insight3. View

Mahil S, Capon F, Barker J . Update on psoriasis immunopathogenesis and targeted immunotherapy. Semin Immunopathol. 2015; 38(1):11-27. PMC: 4706579. DOI: 10.1007/s00281-015-0539-8. View

Anzengruber F, Ghosh A, Maul J, Drach M, Navarini A . Limited clinical utility of HLA-Cw6 genotyping for outcome prediction in psoriasis patients under ustekinumab therapy: a monocentric, retrospective analysis. Psoriasis (Auckl). 2018; 8:7-11. PMC: 5919162. DOI: 10.2147/PTT.S161437. View

Shawkatova I, Javor J, Parnicka Z, Kozub P, Zilinkova M, Frey P . HLA-C, DRB1 and DQB1 alleles involved in genetic predisposition to psoriasis vulgaris in the Slovak population. Folia Microbiol (Praha). 2012; 58(4):319-24. PMC: 3683150. DOI: 10.1007/s12223-012-0213-7. View

Okada Y, Han B, Tsoi L, Stuart P, Ellinghaus E, Tejasvi T . Fine mapping major histocompatibility complex associations in psoriasis and its clinical subtypes. Am J Hum Genet. 2014; 95(2):162-72. PMC: 4129407. DOI: 10.1016/j.ajhg.2014.07.002. View

Al-Mamari F, Al-Shirawi A, Banodkar D, Al-Hashmi S, Al-Yahyaae F, Varghese M . HLA Antigens in Omani Psoriasis Vulgaris Patients. Oman Med J. 2012; 24(1):27-9. PMC: 3269622. DOI: 10.5001/omj.2009.7. View

Ogawa E, Sato Y, Minagawa A, Okuyama R . Pathogenesis of psoriasis and development of treatment. J Dermatol. 2017; 45(3):264-272. DOI: 10.1111/1346-8138.14139. View

Matzaraki V, Kumar V, Wijmenga C, Zhernakova A . The MHC locus and genetic susceptibility to autoimmune and infectious diseases. Genome Biol. 2017; 18(1):76. PMC: 5406920. DOI: 10.1186/s13059-017-1207-1. View

Guarene M, Pasi A, Bolcato V, Cananzi R, Piccolo A, Sbarsi I . The Presence of HLA-A Bw4-80I KIR Ligands Could Predict "Difficult-to-Treat" Psoriasis and Poor Response to Etanercept. Mol Diagn Ther. 2018; 22(4):471-474. DOI: 10.1007/s40291-018-0345-9. View

10.

Barrea L, Nappi F, Di Somma C, Savanelli M, Falco A, Balato A . Environmental Risk Factors in Psoriasis: The Point of View of the Nutritionist. Int J Environ Res Public Health. 2016; 13(5). PMC: 4962284. DOI: 10.3390/ijerph13070743. View

11.

Prinz J . Human Leukocyte Antigen-Class I Alleles and the Autoreactive T Cell Response in Psoriasis Pathogenesis. Front Immunol. 2018; 9:954. PMC: 5936982. DOI: 10.3389/fimmu.2018.00954. View

12.

Costanzo A, Bianchi L, Flori M, Malara G, Stingeni L, Bartezaghi M . Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study. Br J Dermatol. 2018; 179(5):1072-1080. DOI: 10.1111/bjd.16705. View

13.

Atasoy M, Pirim I, Bayrak O, Ozdemir S, Ikbal M, Erdem T . Association of HLA class I and class II alleles with psoriasis vulgaris in Turkish population. Influence of type I and II psoriasis. Saudi Med J. 2006; 27(3):373-6. View

14.

Queiro R, Morante I, Cabezas I, Acasuso B . HLA-B27 and psoriatic disease: a modern view of an old relationship. Rheumatology (Oxford). 2015; 55(2):221-9. DOI: 10.1093/rheumatology/kev296. View

15.

Tsai S, Santamaria P . MHC Class II Polymorphisms, Autoreactive T-Cells, and Autoimmunity. Front Immunol. 2013; 4:321. PMC: 3794362. DOI: 10.3389/fimmu.2013.00321. View

16.

Enamandram M, Kimball A . Psoriasis epidemiology: the interplay of genes and the environment. J Invest Dermatol. 2013; 133(2):287-9. DOI: 10.1038/jid.2012.434. View

17.

Harden J, Krueger J, Bowcock A . The immunogenetics of Psoriasis: A comprehensive review. J Autoimmun. 2015; 64:66-73. PMC: 4628849. DOI: 10.1016/j.jaut.2015.07.008. View

18.

Yin X, Low H, Wang L, Li Y, Ellinghaus E, Han J . Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility. Nat Commun. 2015; 6:6916. PMC: 4423213. DOI: 10.1038/ncomms7916. View

19.

Chandran V, Bull S, Pellett F, Ayearst R, Rahman P, Gladman D . Human leukocyte antigen alleles and susceptibility to psoriatic arthritis. Hum Immunol. 2013; 74(10):1333-8. DOI: 10.1016/j.humimm.2013.07.014. View